Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabrizio.conti@uniroma1.it
Fabrizio Conti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
fabrizio.conti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
VACCINES
2023
Application of Machine Learning Models in Systemic Lupus Erythematosus
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies
REUMATISMO
2023
Janus kinase inhibitors: between prescription authorization and reimbursability
REUMATISMO
2023
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon
AUTOIMMUNITY REVIEWS
2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study
LIFE
2023
Role of Lipid Rafts on LRP8 Signaling Triggered by Anti-β2-GPI Antibodies in Endothelial Cells
BIOMEDICINES
2023
Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Role of lipid rafts on LRP8 signaling triggered by anti-β2-GPI antibodies in endothelial cells
BIOMEDICINES
2023
Should we vaccinate during an active rheumatic disease?
AUTOIMMUNITY REVIEWS
2023
Early and late response and glucocorticoid-sparing effect of belimumab in patients with systemic lupus erythematosus with joint and skin manifestations. results from the belimumab in real life setting study-joint and skin (BeRLiSS-JS)
JOURNAL OF PERSONALIZED MEDICINE
2023
Systematic literature review of real-world evidence on baricitinib for the treatment of rheumatoid arthritis
RHEUMATOLOGY AND THERAPY
2023
Fragility fractures in lupus patients:. associated factors and comparison of four fracture risk assessment tools
LUPUS
2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.
SCIENTIFIC REPORTS
2023
Rheumatoid arthritis from easy to complex disease. from the "2022 GISEA international symposium"
JOURNAL OF CLINICAL MEDICINE
2023
Organ damage in systemic lupus erythematosus patients. a multifactorial phenomenon
AUTOIMMUNITY REVIEWS
2023
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Janus kinase inhibitors: between prescription authorization and reimbursability
REUMATISMO
2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia. a registry-based study
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Exercise-induced modulation of Interferon-signature. a therapeutic route toward management of systemic lupus erythematosus
AUTOIMMUNITY REVIEWS
2023
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
MODULATION OF NEURO-IMMUNE INTERACTION THROUGH JAK INHIBITION IN RHEUMATOID ARTHRITIS
Characterization of regulatory T cells in psoriatic arthritis patients: role of type I interferons in restraining cAMP-mediated immune suppression, and implications for metabolic inflammation.
Activation of salivary gland epithelial cells from different subset of patients with primary Sjögren syndrome: towards a personalized medicine
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma